Cambridge Healthtech Institute’s 8th Annual
Innovative CAR Therapy
In Vivo Cell and Gene Engineering Solutions track
12 November 2025
Cambridge Healthtech Institute's Eighth Annual Innovative CAR Therapy track at PEGS Europe will review innovative CAR structures, cell and gene editing tools, and gene delivery techniques to help design and develop new CAR constructs and engineer therapies in vivo. Various approaches and technologies will be assessed for their immunogenicity and potency, while new modes of delivery, both permanent and transient, will be evaluated. This conference will examine what it will take to transform new CAR constructs and in vivo CAR therapy from proof-of-concept to a robust technology for clinical use.
Coverage will include, but is not limited to:
- Designing CAR constructs to modulate metabolism and harness the TME
- Engineering CAR design to include remote-control, co-stim, logic-gates etc
- Enabling cell therapy for solid tumors
- Creating and optimizing novel CAR constructs
- Engineering and programming cell and genes in vivo
- Advancing various modes of delivery including lipid nanoparticles and mRNA
The deadline for priority consideration is 28 March 2025.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: